Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bolli

Showing results (1191-1200 of 1,218) with videos related to

Pageof 122
Sort By:
Nature Communications|January 17, 2014
Heterogeneity of genomic evolution and mutational profiles in multiple myelomaNiccolo Bolli, Hervé Avet-Loiseau, David C Wedge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2025
Genomics Define Malignant Transformation in Myeloma Precursor ConditionsFrancesco Maura, P Leif Bergsagel, Bachisio Ziccheddu, et al.
European Journal of Heart Failure|April 3, 2021
A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trialRoberto Bolli, Raul D Mitrani, Joshua M Hare, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2021
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic SyndromesMatteo Bersanelli, Erica Travaglino, Manja Meggendorfer, et al.
Nature Communications|April 10, 2014
Processed pseudogenes acquired somatically during cancer developmentSusanna L Cooke, Adam Shlien, John Marshall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2023
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic SyndromesElisabetta Sauta, Marie Robin, Matteo Bersanelli, et al.
Research Square|June 12, 2025
Enhanced Risk Stratification of Smoldering Multiple Myeloma with Dynamic Biomarkers: A Multinational, Multicenter Study including 2,270 Participants (PANGEA 2.0)Floris Chabrun, Daniel Schwartz, Susanna Gentile, et al.
Immunity|December 20, 2025
Positioning and reversible suppression of CCR7<sup>+</sup> dendritic cells in perivascular tumor niches shape cancer immunityBeatrice Zitti, Florent Duval, Pratyaksha Wirapati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2025
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple MyelomaHervé Avet-Loiseau, Faith E Davies, Mehmet K Samur, et al.
Blood|June 14, 2021
Clinical relevance of clonal hematopoiesis in persons aged ≥80 yearsMarianna Rossi, Manja Meggendorfer, Matteo Zampini, et al.
Pageof 122

Showing results (1191-1200 of 1,218) with videos related to

Sort By:
Pageof 122
Nature Communications|January 17, 2014
Heterogeneity of genomic evolution and mutational profiles in multiple myelomaNiccolo Bolli, Hervé Avet-Loiseau, David C Wedge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2025
Genomics Define Malignant Transformation in Myeloma Precursor ConditionsFrancesco Maura, P Leif Bergsagel, Bachisio Ziccheddu, et al.
European Journal of Heart Failure|April 3, 2021
A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trialRoberto Bolli, Raul D Mitrani, Joshua M Hare, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2021
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic SyndromesMatteo Bersanelli, Erica Travaglino, Manja Meggendorfer, et al.
Nature Communications|April 10, 2014
Processed pseudogenes acquired somatically during cancer developmentSusanna L Cooke, Adam Shlien, John Marshall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2023
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic SyndromesElisabetta Sauta, Marie Robin, Matteo Bersanelli, et al.
Research Square|June 12, 2025
Enhanced Risk Stratification of Smoldering Multiple Myeloma with Dynamic Biomarkers: A Multinational, Multicenter Study including 2,270 Participants (PANGEA 2.0)Floris Chabrun, Daniel Schwartz, Susanna Gentile, et al.
Immunity|December 20, 2025
Positioning and reversible suppression of CCR7<sup>+</sup> dendritic cells in perivascular tumor niches shape cancer immunityBeatrice Zitti, Florent Duval, Pratyaksha Wirapati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2025
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple MyelomaHervé Avet-Loiseau, Faith E Davies, Mehmet K Samur, et al.
Blood|June 14, 2021
Clinical relevance of clonal hematopoiesis in persons aged ≥80 yearsMarianna Rossi, Manja Meggendorfer, Matteo Zampini, et al.
Pageof 122